A prospective trial to evaluate pharmacokinetics of ceftaroline fosamil single and repeated dosing in plasma and soft tissues of healthy volunteers

Trial Profile

A prospective trial to evaluate pharmacokinetics of ceftaroline fosamil single and repeated dosing in plasma and soft tissues of healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Ceftaroline fosamil (Primary)
  • Indications Community-acquired pneumonia; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 Apr 2016 Results of population pharmacokinetic modelling presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
    • 04 Apr 2016 Results published in the Antimicrobial Agents and Chemotherapy.
    • 13 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top